Cargando…

Survival analysis of immune-related lncRNA in low-grade glioma

BACKGROUND: Low-grade glioma is grade I-II glioma. Immunotherapy is a promising way of tumor killing. Research on immune molecular mechanisms in low-grade gliomas and discovery of new immune checkpoints for low-grade gliomas are of great importance. METHODS: Gene sequencing data and clinical data of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaozhi, Meng, Yutong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697914/ https://www.ncbi.nlm.nih.gov/pubmed/31419958 http://dx.doi.org/10.1186/s12885-019-6032-3

Ejemplares similares

Immune-Related lncRNA Risk Signatures Predict Survival of IDH Wild-Type and MGMT Promoter Unmethylated Glioblastoma
por: Li, Xiaozhi, et al.
Publicado: (2020)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

Foreboding lncRNA markers of low-grade gliomas dependent on metabolism
por: Lu, Zhuangzhuang, et al.
Publicado: (2022)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

Construction of a SUMOylation regulator‐based prognostic model in low‐grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Expression and prognostic characteristics of m(5)C regulators in low‐grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma
por: Zhang, Qiang, et al.
Publicado: (2021)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration
por: Kang, Kai, et al.
Publicado: (2021)

Antisense lncRNA CHROMR is linked to glioma patient survival
por: Širvinskas, Dovydas, et al.
Publicado: (2023)

Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma
por: Zhao, Jingwei, et al.
Publicado: (2020)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
por: Huang, Qian-Rong, et al.
Publicado: (2022)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients
por: Wang, Yangyang, et al.
Publicado: (2021)

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy
por: Lin, Wanzun, et al.
Publicado: (2020)

Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
por: Wu, Huijie, et al.
Publicado: (2021)

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma
por: Wu, Zhikang, et al.
Publicado: (2022)

Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment
por: Liu, Qing, et al.
Publicado: (2023)

Immune-Related lncRNA Correlated with Transcription Factors Provide Strong Prognostic Prediction in Gliomas
por: Tian, Yixin, et al.
Publicado: (2020)

Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)

Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients
por: Wu, Jie, et al.
Publicado: (2022)

Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration
por: Shi, Zhenyi, et al.
Publicado: (2023)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

Construction and Verification of a Novel Pyroptosis-Related lncRNA Signature Associated with Immune Landscape in Gliomas
por: Feng, Xiaoqiang, et al.
Publicado: (2022)

A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma
por: Zhong, Jiasheng, et al.
Publicado: (2022)

Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis
por: Song, Xiaodong, et al.
Publicado: (2014)

Identification of prognostic immune-related lncRNA signature predicting the overall survival for colorectal cancer
por: Li, Jianxin, et al.
Publicado: (2023)

Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape
por: Hong-bin, Shao, et al.
Publicado: (2022)

Developing a lncRNA Signature to Predict the Radiotherapy Response of Lower-Grade Gliomas Using Co-expression and ceRNA Network Analysis
por: Li, Zhongyang, et al.
Publicado: (2021)

The lncRNA Toolkit: Databases and In Silico Tools for lncRNA Analysis
por: Pinkney, Holly R., et al.
Publicado: (2020)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors
por: Ding, Zuoyou, et al.
Publicado: (2021)

Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model
por: Ma, Chao, et al.
Publicado: (2021)

Prognostic potential of lncRNA RHPN1-AS1 in glioma
por: Wu, Yong, et al.
Publicado: (2020)

Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
por: Lin, Yilin, et al.
Publicado: (2020)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers
por: Shao, Tingting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u7d029c8im5m5mh1og0v7u0919